Cargando…

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries

BACKGROUND: Since 2000, the incidence of measles and rubella has declined as measles–rubella (MR) vaccine coverage increased due to intensified routine immunisation (RI) and supplementary immunisation activities (SIAs). The World Health Assembly commissioned a feasibility assessment of eliminating m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levin, Ann, Burgess, Colleen, Shendale, Stephanie, Morgan, Winthrop, Cw Hutubessy, Raymond, Jit, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335502/ https://www.ncbi.nlm.nih.gov/pubmed/37429697 http://dx.doi.org/10.1136/bmjgh-2022-011526

Ejemplares similares

Strategies for elimination of rubella in pregnancy and of congenital rubella syndrome in high and upper-middle income countries
por: TERRACCIANO, E., et al.
Publicado: (2020)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study
por: Winter, Amy K, et al.
Publicado: (2022)

Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries
por: Levin, Ann, et al.
Publicado: (2014)

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
por: Jit, Mark, et al.
Publicado: (2013)

Costing oral cholera vaccine delivery using a generic oral cholera vaccine delivery planning and costing tool (CholTool)
por: Morgan, Winthrop, et al.
Publicado: (2020)

Stakeholders’ perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study
por: van der Putten, Ingeborg M, et al.
Publicado: (2015)

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries
por: Deogaonkar, Rohan, et al.
Publicado: (2012)

Two-dose measles–rubella vaccine schedule for measles–rubella elimination
por: John, T. Jacob
Publicado: (2023)

Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis
por: Portnoy, Allison, et al.
Publicado: (2019)

Q&A - Economic analyses for vaccine introduction decisions in low- and middle- income countries
por: Hutubessy, Raymond
Publicado: (2013)

Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation
por: Fu, Han, et al.
Publicado: (2023)

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
por: Portnoy, Allison, et al.
Publicado: (2023)

Mapping routine measles vaccination in low- and middle-income countries
Publicado: (2020)

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
por: Brisson, Marc, et al.
Publicado: (2020)

The role of low-income and middle-income country prisons in eliminating hepatitis C
por: Akiyama, Matthew J, et al.
Publicado: (2022)

Estimating national-level measles case–fatality ratios in low-income and middle-income countries: an updated systematic review and modelling study
por: Sbarra, Alyssa N, et al.
Publicado: (2023)

Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa
por: Richardson, Lauren Christine, et al.
Publicado: (2020)

Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
por: Hasso-Agopsowicz, Mateusz, et al.
Publicado: (2022)

Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries
por: Portnoy, Allison, et al.
Publicado: (2020)

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
por: Drolet, Mélanie, et al.
Publicado: (2021)

Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
por: Cutts, F.T., et al.
Publicado: (2020)

Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016–2018
por: Brown, Kevin E., et al.
Publicado: (2019)

Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran
por: Saffar, Hana, et al.
Publicado: (2021)

A review of health worker vaccination programs in low, middle and upper middle-income countries()
por: Gaviola, Gabriel C., et al.
Publicado: (2023)

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
por: Clark, Rebecca A, et al.
Publicado: (2023)

Strengthening routine immunization through measles-rubella elimination
por: Biellik, Robin J., et al.
Publicado: (2018)

Towards elimination of measles and rubella in Italy: Progress and challenges
por: Adamo, Giovanna, et al.
Publicado: (2019)

Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination
por: Wang, Zhifang, et al.
Publicado: (2014)

Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework
por: Carvalho, Natalie, et al.
Publicado: (2017)

Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries
por: Canfell, Karen, et al.
Publicado: (2020)

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
por: Ochalek, Jessica, et al.
Publicado: (2020)

Impact of measles supplementary immunisation activities on utilisation of maternal and child health services in low-income and middle-income countries
por: Postolovska, Iryna, et al.
Publicado: (2018)

Progress Toward Measles and Rubella Elimination — India, 2005–2021
por: Murugan, Ratnesh, et al.
Publicado: (2022)

Progress Toward Measles and Rubella Elimination — Indonesia, 2013–2022
por: Chacko, Stephen, et al.
Publicado: (2023)

Healthcare Workers’ Preparedness: An Exploratory Study for Measles Control in a Middle-Income Country
por: El-Sokkary, Rehab H, et al.
Publicado: (2020)

Measles outbreak investigation process in low- and middle-income countries: a systematic review of the methods and costs of contact tracing
por: Mbivnjo, Etheldreda L., et al.
Publicado: (2021)

The cost-effectiveness of hypertension management in low-income and middle-income countries: a review
por: Kostova, Deliana, et al.
Publicado: (2020)

Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness
por: Horton, Susan, et al.
Publicado: (2017)

Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries
por: Torres-Rueda, Sergio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0hj4pcj03i7ckep0cbmoansrln